Home › NDC Lookup › RxCUI directory › RxCUI 2644878

{1 (chlorpheniramine maleate 0.133 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solu... — RxCUI 2644878

RxNorm drug concept · Generic pack
RxCUI 2644878 Generic pack · GPCK ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2644878
Official name{1 (chlorpheniramine maleate 0.133 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.667 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG per 15 ML Oral Solution) / 1 daytime (dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylephrine HCl 5 MG per 15 ML Oral Solution) Pack; 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 15 mL Oral Solution) / 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution) Pack
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
  • Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
  • With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
  • Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How {1 (chlorpheniramine maleate 0.133 MG/ML / dextr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {1 (chlorpheniramine maleate 0.133 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.667 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) } Pack RxCUI 2644878

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 9

    The active substance itself — no strength, form, or brand attached yet.

    • Chlorpheniramine 2400
    • Dextromethorphan 3289
    • Guaifenesin 5032
    • Phenylephrine 8163
    • Chlorpheniramine / dextromethorphan 214390
    • Dextromethorphan / guaifenesin / phenylephrine 214494
    • Chlorpheniramine maleate 142429
    • Dextromethorphan hydrobromide 102490
    • +1 more in this family
  2. Dose forms 15

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlorpheniramine / dextromethorphan Oral Solution 371456
    • Dextromethorphan / guaifenesin / phenylephrine Oral Solution 375427
    • Chlorpheniramine maleate / dextromethorphan hydrobromide Oral Solution 2645924
    • Dextromethorphan hydrobromide / guaifenesin / phenylephrine hydrochloride Oral Solution 2645876
    • Chlorpheniramine / dextromethorphan Oral Liquid Product 1154179
    • Chlorpheniramine / dextromethorphan Oral Product 1154180
    • Dextromethorphan / guaifenesin / phenylephrine Oral Liquid Product 1154857
    • Dextromethorphan / guaifenesin / phenylephrine Oral Product 1154858
    • +7 more in this family
  3. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 23 of 31 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2644878 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69423-0780-16 1 KIT in 1 PACKAGE (69423-780-16) * 236 mL in 1 BOTTLE, PL... Vicks DayQuil NyQuil BERRY Kids COLD and COUGH plus The Procter & Gamble Manufacturing Company 2023-06-06
69423-0780-24 1 KIT in 1 PACKAGE (69423-780-24) * 236 mL in 1 BOTTLE, PL... Vicks DayQuil NyQuil BERRY Kids COLD and COUGH plus The Procter & Gamble Manufacturing Company 2023-06-06
Observed labelers: The Procter & Gamble Manufacturing Company (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.